These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20228142)

  • 21. Pharmacologic Approach to Management of Clostridium difficile Infection.
    Martin LT; Vincent S; Gillian S; Moore K; Ratermann D; Droege CA
    Crit Care Nurs Q; 2019; 42(1):2-11. PubMed ID: 30507659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile in children: colonisation and disease.
    Enoch DA; Butler MJ; Pai S; Aliyu SH; Karas JA
    J Infect; 2011 Aug; 63(2):105-13. PubMed ID: 21664931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile infection in intestinal transplant recipients.
    Goldenberg V; Berbel A; Camargo JF; Simkins J
    Transpl Int; 2018 Jan; 31(1):116-117. PubMed ID: 28926130
    [No Abstract]   [Full Text] [Related]  

  • 24. Clostridium difficile disease: diagnosis and treatment.
    Surawicz CM
    Gastroenterologist; 1998 Mar; 6(1):60-5. PubMed ID: 9531117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium difficile infection and surgery.
    Gourevitch D; Hawkey P
    Br J Surg; 2009 Jan; 96(1):3-4. PubMed ID: 19109823
    [No Abstract]   [Full Text] [Related]  

  • 26. Epidemic Clostridium difficile.
    Iwata K; Doi A; Furuya N
    N Engl J Med; 2006 Mar; 354(11):1199-203; author reply 1199-203. PubMed ID: 16544391
    [No Abstract]   [Full Text] [Related]  

  • 27. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential for transmission of Clostridium difficile by asymptomatic acute care patients and long-term care facility residents with prior C. difficile infection.
    Jinno S; Kundrapu S; Guerrero DM; Jury LA; Nerandzic MM; Donskey CJ
    Infect Control Hosp Epidemiol; 2012 Jun; 33(6):638-9. PubMed ID: 22561724
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comment on the article by E. Zemanova et al: "Clostridium difficile infection associated with pseudomembranous colitis in district hospitals].
    Zboril V
    Vnitr Lek; 2003 Aug; 49(8):588-9. PubMed ID: 14518079
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile.
    Della-Torre E; Dagna L; Saporiti N
    N Engl J Med; 2009 Feb; 360(6):637; author reply 637-8. PubMed ID: 19202583
    [No Abstract]   [Full Text] [Related]  

  • 32. Nosocomial infections: what needs to be done?
    CMAJ; 2004 Aug; 171(5):421, 423. PubMed ID: 15337706
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous control of norovirus and Clostridium difficile outbreaks due to enhanced infection prevention and control measures.
    Martin AJ; Collins CJ; Ruddy R; Drudy D; Hannan MM; Kyne L
    J Hosp Infect; 2008 Feb; 68(2):180-1. PubMed ID: 18192079
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathway to Prevention of Nosocomial Clostridium difficile Infection.
    Goldstein EJ; Johnson S; Maziade PJ; McFarland LV; Trick W; Dresser L; Millette M; Mazloum H; Low DE
    Clin Infect Dis; 2015 May; 60 Suppl 2():S148-58. PubMed ID: 25922401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive surveillance, control and management programme for Clostridium difficile infection.
    Guzmán A; Del Mar Portillo M; López-Cerero L; García-Ortega L; Lupión C; González C; Gálvez J; Muniain MA; Dolores Del Toro M; Domínguez A; Pascual A; Rodríguez-Baño J
    J Hosp Infect; 2010 Jan; 74(1):91-3. PubMed ID: 19765860
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System.
    Watson T; Hickok J; Fraker S; Korwek K; Poland RE; Septimus E
    Clin Infect Dis; 2018 Jun; 66(12):1957-1959. PubMed ID: 29272341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Refractory Clostridium difficile infection. Untraditional treatment of antibiotic-induced colitis].
    Fløtterød O; Hopen G
    Tidsskr Nor Laegeforen; 1991 Apr; 111(11):1364-5. PubMed ID: 2042156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitors and the risk for Clostridium difficile infection.
    Famularo G; Gasbarrone L; De Simone C
    JAMA; 2009 Jul; 302(1):31-2; author reply 32. PubMed ID: 19567433
    [No Abstract]   [Full Text] [Related]  

  • 40. PPIs: too much of a good thing?
    Drug Ther Bull; 2011 May; 49(5):49. PubMed ID: 21543370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.